BioSpace News Archive

Business

111, Inc. Announces Second Quarter 2022 Unaudited Financial Results

111, Inc. today announced its unaudited financial results for the second quarter ended June 30, 2022.

August 25, 2022
·
21 min read
Business

BioInvent International AB: Interim Report January-June 2022

The second quarter 2022 was eventful for BioInvent, delivering a deal with the US biotech company Exelixis, positive progress in our clinical portfolio and strengthened organizational leadership.

August 25, 2022
·
3 min read
Biotech Bay

3T Biosciences Debuts with $40 Million Series A Financing

3T Biosciences, an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, announced its launch from stealth backed by $40 million Series A financing led by Westlake Village BioPartners with participation from Lightspeed Venture Partners.

August 25, 2022
·
10 min read
Drug Development

Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate

Pfizer Inc. announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older.

August 25, 2022
·
9 min read
Drug Development

Elevar Therapeutics Announces Data From Phase 3 Study of Rivoceranib in Combination With Camrelizumab Is Accepted for Late-Breaking Proffered Paper Presentation at ESMO Congress 2022

Elevar Therapeutics, Inc. today announced that initial data from the Phase 3 study of its drug candidate rivoceranib was accepted for a late-breaking proffered paper presentation at the annual Congress of the European Society for Medical Oncology (ESMO) on September 10, 2022 in Paris.

August 25, 2022
·
3 min read
Business

ASLAN Pharmaceuticals Signs License Agreement With Belle.ai to Use belleStudy™ Image Capture Software in Atopic Dermatitis Clinical Trials

BelleTorus Corporation (“Belle.ai”) and ASLAN Pharmaceuticals (Nasdaq: ASLN), today announced that ASLAN has licensed belleStudy™ digital image capture software in support of ASLAN’s clinical trials for atopic dermatitis (AD) across several global sites.

August 25, 2022
·
3 min read
Sharecare to participate in 2022 Wells Fargo Healthcare Conference

Sharecare today announced that it will participate in the 2022 Wells Fargo Healthcare Conference, including a presentation on Wednesday, September 7, 2022 , at 8:35 a.m. E.T.

August 25, 2022
·
1 min read
Business

Tigermed Reports 2022 Interim Result with Strong Financial Growth

Hangzhou Tigermed Consulting Co., Ltd. announced its interim results for the first half of 2022, ended June 30, 2022.

August 25, 2022
·
9 min read
Genetown

Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome

Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) the maker of Plenity for weight management, today released a poster presentation at the International Congress of Endocrinology in Singapore.

August 25, 2022
·
11 min read
BioCapital

OpGen Launches Ares Sequencing Services in the U.S. from its Rockville, Maryland Laboratory

OpGen, Inc announced today that it has launched next generation sequencing (NGS) services in the U.S. that were developed by its subsidiary, Ares Genetics (“Ares”), which strives to become a leader in bacterial genomics and artificial intelligence (AI)-powered antimicrobial resistance (AMR) solutions.

August 25, 2022
·
6 min read